ADVANCED/ METASTATIC SOLID TUMORS
Clinical trials for ADVANCED/ METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/ METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED/ METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New trial aims to personalize cancer treatment using rapid immune profiling
Disease control Not yet recruitingThis trial aims to improve cancer treatment by matching patients with advanced solid tumors to specific immunotherapies based on a detailed analysis of their individual tumor and immune system. Researchers will use a rapid testing platform called PORTRAIT on fresh blood and tumor…
Matched conditions: ADVANCED/ METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New pill targets advanced cancers in first human test
Disease control Not yet recruitingThis is the first study in people to test a new oral drug called HLX97. It aims to find a safe dose and see early signs of whether it can help control advanced cancers that have spread. The trial will enroll about 138 adults with specific advanced solid tumors, like certain breas…
Matched conditions: ADVANCED/ METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New cancer drug enters first human trials for advanced tumors
Disease control Not yet recruitingThis is the first human study of a new cancer drug called HLX48, designed to test its safety and how it moves through the body. The trial will enroll 72 adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will give increasing doses t…
Matched conditions: ADVANCED/ METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC